ABSA International
ABSA International

Resources with keywords: IPC



EBOLA BUNDIBUGYO VIRUS DISEASE OUTBREAK Democratic Republic of the Congo | Uganda Weekly External Situation Report 01, Data as of 18 May 2026
WHO
18 May 2026

Outbreak originated in a healthcare facility in Mongbwalu Health Zone, Ituri. HCW exposure documented in the index cluster. WHO deploying IPC surge teams. Alert to U.S. hospital infection control teams: any patient presenting with hemorrhagic fever syndrome and travel history to Ituri/N. Kivu requires immediate isolation and notification.

Epidemic of Ebola Disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a public health emergency of international concern
WHO
17 May 2026

Bundibugyo virus is a BSL-4/Select Agent pathogen with no licensed vaccine or therapeutic. As of 26 May 2026: 105 confirmed + 906 suspected cases; ≥234 deaths in DRC (Ituri, N. Kivu, S. Kivu); 7 confirmed cases in Uganda. Healthcare workers without adequate PPE face high infection risk. U.S. labs handling Ebola must comply with FSAP Tier 1 requirements. All clinical laboratories must implement immediate IPC measures for patients with travel history to DRC/Uganda.

Go to Top